SMBT
IBB icon

Southern Michigan Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Southern Michigan Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Hold
100
– – 0.01% 286
2026
Q1 		$16.9K Buy
+100
New +$17.1K 0.01% 287

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Southern Michigan Bank & Trust's IBB Position: Q2 2026 in Review

Southern Michigan Bank & Trust held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 100 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #286.

Southern Michigan Bank & Trust first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. 926 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Southern Michigan Bank & Trust held 100 shares of iShares Biotechnology ETF worth $19K as of Q2 2026.
  • Southern Michigan Bank & Trust left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Southern Michigan Bank & Trust's portfolio in Q2 2026, its #286 holding.
  • Southern Michigan Bank & Trust first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • 926 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Southern Michigan Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.